Home » Topics » BioWorld Science

BioWorld Science
RSS

Axovant reports exploratory phase II study results for nelotanserin

Dec. 11, 2018

Itanapraced demonstrates animal proof of concept in Parkinson's disease models

Dec. 11, 2018

Immix reports interim findings from phase Ib/IIa study of IMX-110 in advanced solid tumors

Dec. 11, 2018

Arctic Pharma discovers lactate dehydrogenase A inhibitors

Dec. 11, 2018

Shionogi and Ube establish strategic research collaboration in RSV

Dec. 11, 2018

Vanderbilt University synthesizes RAS GTPase inhibitors

Dec. 11, 2018

Prescient Therapeutics reports interim durability data on PTX-200 in breast cancer

Dec. 11, 2018

WDR5/MLL1 interaction inhibitors identified at the University of Michigan

Dec. 11, 2018

LegoChem Biosciences patents E-NPP 2 inhibitors

Dec. 11, 2018

Oppilan Pharma presents sphingosine 1-phosphate receptor 1 agonists

Dec. 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...